← Back to patent-cliff list
CAS 75-07-0
Ethanal
Codes: Atorvastatin-035, Metronidazole hydrochloride-002, Alprazolam-013
Application context (from source-drug indications)
Cardiac and vascular disordersAtorvastatin/Hydrochlorothiazide/Aspirin/EnalaprilHypertensionAtorvastatin/Hydrochlorothiazide/Aspirin/EnalaprilHyperlipidaemiaAtorvastatin/Hydrochlorothiazide/Aspirin/EnalaprilHeart diseaseAtorvastatin/Hydrochlorothiazide/Aspirin/EnalaprilDuodenal ulcerRabeprazole Sodium/Metronidazole/AmoxicillinImmune thrombocytopenic purpuraRabeprazole Sodium/Metronidazole/AmoxicillinGastric ulcerRabeprazole Sodium/Metronidazole/AmoxicillinGastritisRabeprazole Sodium/Metronidazole/AmoxicillinHelicobacter pylori infectionRabeprazole Sodium/Metronidazole/AmoxicillinAnxietyParoxetine/AlprazolamDepressionParoxetine/AlprazolamTrichomoniasisMiconazole/Metronidazole/LidocaineCandidiasisMiconazole/Metronidazole/LidocaineVaginitisMiconazole/Metronidazole/LidocaineHyperlipidaemiaAtorvastatin strontiumSubarachnoid haemorrhageAtorvastatin strontiumHypertensionAtorvastatin strontiumBacterial infectionMetronidazole hydrochlorideIntra-abdominal infectionMetronidazole hydrochlorideBacteraemiaMetronidazole hydrochlorideSkin and skin structure infectionMetronidazole hydrochlorideLower respiratory tract infectionMetronidazole hydrochlorideEndocarditisMetronidazole hydrochlorideAnxiety disorderAlprazolamPanic disorderAlprazolamAnxietyAlprazolamEpilepsyAlprazolamType 1 diabetesAlprazolamSubstance-related disorderAlprazolam
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Atorvastatin/Hydrochlorothiazide/Aspirin/Enalapril | Tier C — Watch / trade | - |
| Rabeprazole Sodium/Metronidazole/Amoxicillin | Tier C — Watch / trade | - |
| Paroxetine/Alprazolam | Tier C — Watch / trade | - |
| Miconazole/Metronidazole/Lidocaine | Tier C — Watch / trade | - |
| Atorvastatin strontium | Tier C — Watch / trade | - |
| Metronidazole hydrochloride | Tier C — Watch / trade | - |
| Alprazolam | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
Benzyl (3-oxopropyl)carbamate→Ethanal→Benzyl [2-[(2R,4R)-4,6-dihydroxytetrahydro-2H-pyran-2-yl]ethyl]carbamate→Benzyl [2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl]carbamate→(4R,6R)-6-(2-aminoethyl)-4-hydroxyoxan-2-one→5-(4-Fluorophenyl)-1-[2-[4(R)-hydroxy-6-oxotetrahydropyran-2(R)-yl]ethyl]-2-isopropyl-N,4-diphenyl-1H-pyrrole-3-carboxamide→2-[2-(4-Fluorophenyl)-2-oxo-1-phenylethyl]-4-methyl-3-oxo-N-phenylpentanamide
Rabeprazole Sodium/Metronidazole/AmoxicillinOptimised routesteps: 6total yield: 8.5g(Metronidazole (Free))
Glyoxal→Ethanal→2-Methylglyoxaline→2-Methyl-4(5)-nitroimidazole→Ethylene chlorohydrin→Ethyl nitrile→Methyl ethanimidoate hydrochloride→2,2-Dimethoxyethanamine→N-(2,2-Dimethoxyethyl)ethanimidamide
(2Z)-7-chloro-2-hydrazinylidene-5-phenyl-1,3-dihydro-1,4-benzodiazepine→Ethanal→(2Z)-7-chloro-2-[(2E)-2-ethylidenehydrazin-1-ylidene]-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepine
Glyoxal→Ethanal→2-Methylglyoxaline→2-Methyl-4(5)-nitroimidazole→Ethylene chlorohydrin→Ethyl nitrile→Methyl ethanimidoate hydrochloride→2,2-Dimethoxyethanamine→N-(2,2-Dimethoxyethyl)ethanimidamide
Benzyl (3-oxopropyl)carbamate→Ethanal→Benzyl [2-[(2R,4R)-4,6-dihydroxytetrahydro-2H-pyran-2-yl]ethyl]carbamate→Benzyl [2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl]carbamate→(4R,6R)-6-(2-aminoethyl)-4-hydroxyoxan-2-one→5-(4-Fluorophenyl)-1-[2-[4(R)-hydroxy-6-oxotetrahydropyran-2(R)-yl]ethyl]-2-isopropyl-N,4-diphenyl-1H-pyrrole-3-carboxamide→2-[2-(4-Fluorophenyl)-2-oxo-1-phenylethyl]-4-methyl-3-oxo-N-phenylpentanamide
Glyoxal→Ethanal→2-Methylglyoxaline→2-Methyl-4(5)-nitroimidazole→Ethylene chlorohydrin→Ethyl nitrile→Methyl ethanimidoate hydrochloride→2,2-Dimethoxyethanamine→N-(2,2-Dimethoxyethyl)ethanimidamide
(2Z)-7-chloro-2-hydrazinylidene-5-phenyl-1,3-dihydro-1,4-benzodiazepine→Ethanal→(2Z)-7-chloro-2-[(2E)-2-ethylidenehydrazin-1-ylidene]-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepine
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.